These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34123681)

  • 21. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
    Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
    J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-Onset Euglycemic Diabetic Ketoacidosis in a Patient With Massive Stroke Requiring Decompressive Craniectomy: A Case Report.
    Hussaini SA; Aziz A; Musa M; Alamin M; Danjuma M
    Cureus; 2021 Oct; 13(10):e18629. PubMed ID: 34765377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
    Osafehinti DA; Okoli OJ; Karam JG
    AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
    Gajjar K; Luthra P
    Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.
    Pujara S; Ioachimescu A
    J Investig Med High Impact Case Rep; 2017; 5(2):2324709617710040. PubMed ID: 28589154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.
    Andrews TJ; Cox RD; Parker C; Kolb J
    J Emerg Med; 2017 Feb; 52(2):223-226. PubMed ID: 27717592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.
    Iqbal QZ; Mishiyev D; Zia Z; Ruggiero RA; Aftab G
    Cureus; 2020 Oct; 12(10):e10878. PubMed ID: 33178530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report.
    VonTungeln CD; Al Bataineh M
    Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series.
    Shah M; Pathrose E; Bhagwat NM; Chandy D
    Indian J Crit Care Med; 2022 Jan; 26(1):123-126. PubMed ID: 35110855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
    Mistry S; Eschler DC
    AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report.
    Fukuda M; Nabeta M; Muta T; Fukami K; Takasu O
    Int J Emerg Med; 2020 Jan; 13(1):2. PubMed ID: 31969112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports.
    Altowayan WM
    Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
    Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
    Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misleading Presentation: Chest Pain Masking Euglycemic Diabetic Ketoacidosis Possibly Induced by Empagliflozin.
    Tiwari K; Sharma NR; Pokhrel M; Basnet A; Kaplan M
    Cureus; 2023 Nov; 15(11):e49402. PubMed ID: 38149142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient Who Underwent Surgery for Pancreatic Carcinoma: A Case Report.
    Luo X; Ji R; Lu W; Zhu H; Li L; Hu J
    Front Surg; 2022; 9():769041. PubMed ID: 35284482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors.
    Fukuyama Y; Numata K; Yoshino K; Santanda T; Funakoshi H
    Acute Med Surg; 2020; 7(1):e480. PubMed ID: 31988792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SGLT-2 Inhibitors-a Culprit of Diabetic Ketoacidosis Postbariatric Surgery.
    Iqbal QZ; Mishiyev D; Niazi MR; Zia Z; Sattar SBA; Jahanghir A; Quyyumi S
    Case Rep Crit Care; 2020; 2020():8817829. PubMed ID: 33204542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canagliflozin-associated diabetic ketoacidosis: a case report.
    Chai PR; Bonney C; Blohm E; Boyer EW; Babu KM
    Toxicol Commun; 2017; 1(1):2-5. PubMed ID: 29978156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Euglycemic Diabetic Ketoacidosis Caused by a Sodium-glucose Co-transporter (SGLT) 2 Inhibitor after Coronary Artery Bypass Grafting].
    Kameda Y; Kato M; Inoue B; Yamazaki S; Sahara N; Aoki T; Nagashima Y; Nemoto N; Anzai H; Araki W; Kobayashi N
    Kyobu Geka; 2019 May; 72(5):354-357. PubMed ID: 31268032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation.
    Tauseef A; Asghar MS; Zafar M; Lateef N; Thirumalareddy J
    Cureus; 2020 Aug; 12(8):e10078. PubMed ID: 33005504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.